| The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes LA Carey, EC Dees, L Sawyer, L Gatti, DT Moore, F Collichio, DW Ollila, ... Clinical cancer research 13 (8), 2329-2334, 2007 | 2795 | 2007 |
| Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JC Boughey, VJ Suman, EA Mittendorf, GM Ahrendt, LG Wilke, B Taback, ... Jama 310 (14), 1455-1461, 2013 | 1539 | 2013 |
| Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 … AE Giuliano, KV Ballman, L McCall, PD Beitsch, MB Brennan, ... Jama 318 (10), 918-926, 2017 | 1535 | 2017 |
| Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma RR Turner, DW Ollila, DL Krasne, AE Giuliano Annals of surgery 226 (3), 271-278, 1997 | 817 | 1997 |
| Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus … LA Carey, DA Berry, CT Cirrincione, WT Barry, BN Pitcher, LN Harris, ... Journal of Clinical Oncology 34 (6), 542, 2016 | 398 | 2016 |
| Surgical resection for melanoma metastatic to the gastrointestinal tract DW Ollila, R Essner, LA Wanek, DL Morton Archives of surgery 131 (9), 975-980, 1996 | 347 | 1996 |
| Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study NE Thomas, KJ Busam, L From, A Kricker, BK Armstrong, H Anton-Culver, ... Journal of Clinical Oncology 31 (33), 4252, 2013 | 301 | 2013 |
| Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging RR Turner, DW Ollila, S Stern, AE Giuliano The American journal of surgical pathology 23 (3), 263-267, 1999 | 293 | 1999 |
| Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma NE Thomas, SN Edmiston, A Alexander, RC Millikan, PA Groben, H Hao, ... Cancer Epidemiology Biomarkers & Prevention 16 (5), 991-997, 2007 | 265 | 2007 |
| American joint committee on cancer tumor–node–metastasis stage after neoadjuvant chemotherapy and breast cancer outcome LA Carey, R Metzger, EC Dees, F Collichio, CI Sartor, DW Ollila, ... Journal of the National Cancer Institute 97 (15), 1137-1142, 2005 | 249 | 2005 |
| Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine EC Hsueh, R Essner, LJ Foshag, DW Ollila, G Gammon, SJ O’Day, ... Journal of clinical oncology 20 (23), 4549-4554, 2002 | 242 | 2002 |
| Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control … WG Cance, LA Carey, BF Calvo, C Sartor, L Sawyer, DT Moore, ... Annals of surgery 236 (3), 295-303, 2002 | 228 | 2002 |
| Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma NE Thomas, SN Edmiston, A Alexander, PA Groben, E Parrish, A Kricker, ... JAMA oncology 1 (3), 359-368, 2015 | 195 | 2015 |
| Impact of neoadjuvant chemotherapy in stage II–III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results … M Golshan, CT Cirrincione, WM Sikov, DA Berry, S Jasinski, TF Weisberg, ... Annals of surgery 262 (3), 434-439, 2015 | 185 | 2015 |
| Metastasectomy for recurrent stage IV melanoma DW Ollila, EC Hsueh, SL Stern, DL Morton Journal of surgical oncology 71 (4), 209-213, 1999 | 171 | 1999 |
| Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? SL Blair, K Thompson, J Rococco, V Malcarne, PD Beitsch, DW Ollila Journal of the American College of Surgeons 209 (5), 608-613, 2009 | 165 | 2009 |
| Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study NE Thomas, A Kricker, WT Waxweiler, PM Dillon, KJ Busam, L From, ... JAMA dermatology 150 (12), 1306-1314, 2014 | 162 | 2014 |
| Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment EL Rager, EP Bridgeford, DW Ollila American family physician 72 (2), 269-276, 2005 | 155 | 2005 |
| Complete metastasectomy in patients with stage IV metastatic melanoma DW Ollila The lancet oncology 7 (11), 919-924, 2006 | 153 | 2006 |
| LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma W Liu, KB Monahan, AD Pfefferle, T Shimamura, J Sorrentino, KT Chan, ... Cancer cell 21 (6), 751-764, 2012 | 140 | 2012 |
